/PRNewswire/ AMPEL BioSolutions today announces a breakthrough in precision and personalized medicine that could revolutionize the way doctors treat chronic.
Experts say some people who have no traditional risk factors for cardiovascular disease may have a genetic predisposition to suffer heart attacks or strokes at an early age, and a Charlottesville company has now produced a blood test that could identify them. Sandy Hausman has that story.
/PRNewswire/ AMPEL BioSolutions today announced a genetic precision medicine test for lupus patients that could save lives by predicting heart disease.
/PRNewswire/ AMPEL BioSolutions today announced a breakthrough in precision and personalized medicine that can detect and predict the severity of COVID-19.